Human Milk Oligosaccharides Market Size, Share & Trends Analysis Report By Type (2'FL, 6'SL), By Concentration, By Application (Infant Formula, Dietary Supplement), By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segmental Outlook
2.3. Competitive Insights
Chapter 3. Human Milk Oligosaccharides Market Variables, Trends, & Scope
3.1. Market Outlook
3.1.1. Parent Market Outlook
3.1.2. Related Market Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Major Raw Material Trends
3.3.2. Manufacturing Trends
3.4. Technology Overview
3.5. Regulatory Framework
3.6. Vendor Selection Criteria Analysis
3.7. Market Dynamics
3.7.1. Market driver Analysis
3.7.2. Market Restraint Analysis
3.7.3. Industry Challenges
3.8. Business Environment Analysis: Human Milk Oligosaccharides Market
3.8.1. Industry Analysis - Porter’s
3.8.1.1. Supplier Power
3.8.1.2. Buyer Power
3.8.1.3. Substitution Threat
3.8.1.4. Threat from New Entrant
3.8.1.5. Competitive Rivalry
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2.环境景观
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Economic Landscape
3.8.2.6. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.9. Market Entry Strategies
Chapter 4. Human Milk Oligosaccharides Market: Application Estimates & Trend Analysis
4.1. Human Milk Oligosaccharides: Application movement analysis, 2019 & 2027
4.2. Infant Formula
4.2.1. Market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
4.3. Functional Food & Beverages
4.3.1. Market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
4.4. Food Supplements
4.4.1. Market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
4.5. Others
4.5.1. Market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Chapter 5. Human Milk Oligosaccharides Market: Regional Estimates & Trend Analysis
5.1. SWOT Analysis
5.1.1. North America
5.1.2. Europe
5.1.3. Asia Pacific
5.1.4. Central & South America
5.1.5. Middle East & Africa
5.2. Human Milk Oligosaccharides: Regional movement analysis, 2019 & 2027
5.3. North America
5.3.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.3.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.3.3. The U.S.
5.3.3.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.3.3.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.3.4. Canada
5.3.4.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.3.4.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.3.5. Mexico
5.3.5.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.3.5.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.4. Europe
5.4.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.4.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.4.3. Germany
5.4.3.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.4.3.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.4.4. U.K.
5.4.4.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.4.4.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.4.5. France
5.4.5.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.4.5.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.5. Asia Pacific
5.5.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.5.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.5.3. China
5.5.3.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.5.3.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.5.4. Japan
5.5.4.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.5.4.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.5.5. India
5.5.5.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.5.5.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.6. Central & South America
5.6.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.6.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.6.3. Brazil
5.6.3.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.6.3.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.7. Middle East & Africa
5.7.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.7.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
5.7.3. UAE
5.7.3.1. Market Estimates and Forecasts, 2017 - 2030 (Tons) (USD Million)
5.7.3.2. Market Estimates and Forecasts, By Application, 2017 - 2030 (Tons) (USD Million)
Chapter 6. Human Milk Oligosaccharides Market: Competitive Analysis
6.1. Key Global Players, Their Initiatives, & Their Impact on the Market
6.2. Participant Categorization
6.3. Vendor Landscape
6.3.1. List of key distributors & channel partners
6.4. Public Companies
6.4.1. Company Market Position Analysis
6.4.2. Competitive Dashboard Analysis
6.4.2.1. Market Differentiators
6.4.3. SWOT Analysis
6.5. Private Companies
6.5.1. Innovators/Emerging Company
6.5.2. Geographical Presence
6.5.3. Company market position analysis
Chapter 7. Company Profiles
7.1. Inbiose NV
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. Elicityl S.A
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Jennewein Biotechnologie GmbH
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. Glycom A/S
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Medolac Laboratories
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. ZuChem Inc
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. Glycosyn LLC
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. Abbott
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Dextra Laboratories Ltd
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
7.10. DuPont
7.10.1. Company Overview
7.10.2. Financial Performance
7.10.3. Product Benchmarking
7.10.4. Strategic Initiatives

List of Tables

Table 1 Human milk oligosaccharides (HMO) market - Driver analysis
Table 2 Human milk oligosaccharides (HMO) market - Restraint analysis
Table 3 2’FL Specifications
Table 4 2’FL Key Suppliers
Table 5 2’FL Patents
Table 6 3’FL Specifications
Table 7 3’FL Key Suppliers
Table 8 3’FL Patents
Table 9 3’-Sialyllactose (3’SL) Specifications
Table 10 3’-Sialyllactose (3’SL) Suppliers
Table 11 3’-Sialyllactose (3’SL) Patents
Table 12 6’SL Specifications
表13 6 'sl关键供应商s
Table 14 6’SL Patents
Table 15 LNT Specifications
Table 16 LNT Suppliers
Table 17 LNT Patents
Table 18 LNnT Specifications
Table 19 LNnT Suppliers
Table 20 LNnT Patents
Table 21 Global HMO market estimates and forecast in infant formula, 2017 - 2030 (Tons) (USD Million)
Table 22 Global HMO market estimates and forecast in infant formula, by region, 2017 - 2030 (Tons)
Table 23 Global HMO market estimates and forecast in infant formula, by region, 2017 - 2030 (USD '000)
Table 24 Global HMO market estimates and forecast in functional food & beverages, 2017 - 2030 (Tons) (USD Million)
Table 25 Global HMO market estimates and forecast in functional food & beverages, by region, 2017 - 2030 (Tons)
Table 26 Global HMO market estimates and forecast in functional food & beverages, by region, 2017 - 2030 (USD '000)
Table 27 Global HMO market estimates and forecast in food supplements, 2017 - 2030 (Tons) (USD Million)
Table 28 Global HMO market estimates and forecast in food supplements, by region, 2017 - 2030 (Tons)
Table 29 Global HMO market estimates and forecast in food supplements, by region, 2017 - 2030 (USD '000)
Table 30 Global HMO market estimates and forecast in others, 2017 - 2030 (Tons) (USD Million)
Table 31 Global HMO market estimates and forecast in others, by region, 2017 - 2030 (Tons)
Table 32 Global HMO market estimates and forecast in others, by region, 2017 - 2030 (USD '000)
Table 33 North America HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 34 North America HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 35 North America HMO market estimates and forecasts, by application, 2017 - 2030 (USD '000)
Table 36 U.S HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 37 U.S HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 38 U.S HMO market estimates and forecasts, by application, 2017 - 2030 (USD '000)
Table 39 Canada HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 40 Canada HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 41 Canada HMO market estimates and forecasts, by application, 2017 - 2030 (USD '000)
表42墨西哥HMO市场估计和预测, 2017 - 2030 (Tons) (USD Million)
Table 43 Mexico HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 44 Mexico HMO market estimates and forecasts, by application, 2017 - 2030 (USD '000)
Table 45 Europe HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 46 Europe HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 47 Europe HMO market estimates and forecasts, by application, 2017 - 2030 (USD '000)
Table 48 U.K. HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 49 U.K. HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 50 U.K. HMO market estimates and forecasts, by application, 2017 - 2030 (USD '000)
Table 51 Germany HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 52 Germany HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 53 Germany HMO market estimates and forecasts, by application, 2017 - 2030 (USD '000)
Table 54 France HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 55 France HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 56 France HMO market estimates and forecasts, by application, 2017 - 2030 (USD '000)
Table 57 Asia Pacific HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 58 Asia Pacific HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 59 Asia Pacific HMO market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 60 China HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 61 China HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 62 China HMO market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 63 Japan HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 64 Japan HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 65 Japan HMO market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 66 India HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 67 India HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 68 India HMO market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 69 Central & South America HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 70 Central & South America HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 71 Central & South America HMO market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 72 Brazil HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 73 Brazil HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 74 Brazil HMO market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 75 MEA HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
Table 76 MEA HMO market estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 77 MEA HMO market estimates and forecasts, by application, 2017 - 2030 (USD Million)
Table 78 UAE HMO market estimates and forecasts, 2017 - 2030 (Tons) (USD Million)
表79年阿联酋HMOmarket estimates and forecasts, by application, 2017 - 2030 (Tons)
Table 80 UAE HMO market estimates and forecasts, by application, 2017 - 2030 (USD Million)

List of Figures

Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Primary research process
Fig. 4 Primary research approaches
Fig. 5 Human milk oligosaccharides (HMO) market snapshot, 2022 (USD Million)
Fig. 6 Human milk oligosaccharides (HMO) market segmentation
Fig. 7 Human milk oligosaccharides (HMO) market volume and revenue estimates and forecast, 2016 – 2027 (USD Thousand) (Tons)
Fig. 8 Value chain analysis
Fig. 9 Raw material outlook
Fig. 10 Market dynamics
Fig. 11 Global trade in dairy products, 2020 and 2021 (Thousand Tons)
Fig. 12 Global HMO market, 2017 - 2030 (USD Million)
Fig. 13 Human milk oligosaccharides - Key opportunities prioritized
Fig. 14 Human milk oligosaccharides - Strategy framework
Fig. 15 Human milk oligosaccharides - Porter’s analysis
Fig. 16 Human milk oligosaccharides - PESTEL analysis
Fig. 17 Human milk oligosaccharides: Application movement & market share analysis, 2022 & 2030
Fig. 18 Human milk oligosaccharides: Regional movement & market share analysis, 2022 & 2030